Polymer stabilization of chromogen solutions

US9618429B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9618429-B2
Application numberUS-201313744504-A
CountryUS
Kind codeB2
Filing dateJan 18, 2013
Priority dateJan 23, 2012
Publication dateApr 11, 2017
Grant dateApr 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed embodiments concern a composition comprising DAB chromogen, and/or derivative thereof, a stabilizer, and polymer capable of preventing or reducing DAB precipitation relative to a composition that does not comprise the polymer. Also disclosed herein is a method for using the disclosed composition and embodiments of a kit.

First claim

Opening claim text (preview).

We claim: 1. A composition for chromogenic immunohistochemistry comprising in a solution: a) a solvent, b) a DAB chromogen or a derivative thereof, c) a stabilizer, and d) a polyethyleneimine polymer soluble in the solvent. 2. The composition of claim 1 , wherein the polyethyleneimine polymer is a 4 kDa HCl salt of polyethyleneimine. 3. The composition of claim 1 , wherein the polyethyleneimine polymer has a number average molecular weight of between about 1 kDa and about 500 kDa. 4. The composition of claim 1 , wherein the polyethyleneimine polymer is about 0.05 percent to about 10 percent of the solution by weight. 5. The composition of claim 1 , wherein the DAB chromogen or the derivative thereof has a concentration of about 0.1 mM to about 100 mM. 6. The composition of claim 1 , further comprising an enhancer selected from the group consisting of imidazole, 2-hydroxypyridine, and combinations thereof. 7. The composition of claim 1 , wherein the stabilizer is sodium metabisulfite. 8. The composition of claim 1 , wherein the polyethyleneimine polymer is configured to form a complex with the DAB chromogen or the derivative thereof so as to maintain solubility of the DAB chromogen or the derivative thereof in the solvent. 9. The composition of claim 1 , wherein the stabilizer and the polyethyleneimine polymer substantially prevent the DAB chromogen or the derivative thereof from decomposing and/or being oxidized under storage conditions. 10. A composition for chromogenic immunohistochemistry detection comprising a DAB chromogen, a stabilizer, and a polymer; wherein the stabilizer is sodium metabisulfite or sodium bisulfite, and the polymer is polyethyleneimine, wherein the composition is configured to remain stable under storage conditions so that the polymer complexes the DAB chromogen or the derivative thereof so as to maintain the amount of the DAB chromogen or the derivative thereof in the solution, and wherein the composition is configured so that the DAB precipitates under detection conditions to produce a signal suitable for chromogenic immunohistochemistry. 11. The composition of claim 10 , wherein the DAB chromogen is 3,3′-diaminobenzidine, and the stabilizer is sodium metabisulfite, and the polymer is polyethyleneimine. 12. The composition of claim 11 , wherein the composition comprises about 1 to about 15 mM 3,3′-diaminobenzidine, about 0.1 to about 6 mM sodium metabisulfite and about 0.05% to about 0.5% (w/w) polyethyleneimine.

Assignees

Inventors

Classifications

  • C12Q1/28Primary

    involving peroxidase · CPC title

  • Production of labelled immunochemicals · CPC title

  • G01N1/30Primary

    Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis} · CPC title

  • with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title

  • with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9618429B2 cover?
Disclosed embodiments concern a composition comprising DAB chromogen, and/or derivative thereof, a stabilizer, and polymer capable of preventing or reducing DAB precipitation relative to a composition that does not comprise the polymer. Also disclosed herein is a method for using the disclosed composition and embodiments of a kit.
Who is the assignee on this patent?
Ventana Med Syst Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).